Contribution of brain no synthase activity to the indapamide-induced prevention of experimental hypertension

Homeostasis in Health and Disease

Volumn 44, Issue 3, 2006, Pages 104-108

  Kojšová, Stanislava ^a   Jendeková, Lýdia ^a   Paulis, L'udovít ^a,b   Pecháňová, Ol'ga ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Physics and Informatics   (Slovakia)

Author keywords

Cerebellum; Hydrochlorothiazide; Indapamide; L NAME induced hypertension; Nitric oxide

Indexed keywords

BRAIN ENZYME; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; CEREBELLUM; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; EXPERIMENTAL RAT; HYPERTENSION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SYSTOLIC BLOOD PRESSURE;

EID: 35148814962     PISSN: 09607560     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bada V. Nová lieková forma indapamidu SR, alebo sú všetky diuretiká rovnaké? Cardiol 13: 150-156, 2004.
2. Bernátová I., Pecháňová O., Šimko F. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Exp Physiol 84: 1095-105, 1999.
3. Boulanger C. M., Mombouli J. V., Vanhoutte P. M. Indapamide inhibits endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Fundam Clin Pharmacol 7: 443-448, 1993.
4. Bredt D. S., Snyder S. H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A 87: 682-685, 1990.
5. Cifkova R. Arterial hypertension as a public health issue in the Czech Republic. Blood Press Suppl 2: 25-28, 2005.
6. Dukát A. Ambulatory blood pressure monitoring during hypertension therapy. Bratisl Lek Listy 99: 119-120, 1998.
7. Jendeková L., Csizmadiová Z., Kojšová S., Pechánová O. Motor activity in spontaneously and L-NAME hypertensive rats: The role of nitric oxide. Homeostasis 43: 205-209, 2005.
8. Levy B. I., Poitevin P., Safar M. E. Effects of indapamide on the mechanical properties of the arterial wall in deoxycorticosterone acetate-salt hypertensive rats. Am J Cardiol 65: 28H-32H, 1990.
9. Marre M., Garcia Puig J., Kokot F., Fernandez M., Jermendy G., Opie L., Moyseev V., Scheen A., Ionescu-Tirgoviste C., Saldanha M. H., Halabe A., Williams B., Mion D. Jr., Ruiz M., Hermansen K., Tuomilehto J., Finizola B., Pozza G., Chastang C., Ollivier J. P., Amouyel P., Asmar R. Effect of indapamide SR on microalbuminuria - the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia) - rationale and protocol for the main trial. J Hypertens Suppl 21: S19-24, 2003.
10. Pechánová O., Bernátová I., Pelouch V., Šimko F. Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril. J Mol Cell Cardiol 29: 3365-3374, 1997.
11. Pechánová O., Jendeková L., Kojšová S., Jagla F. Possible role of nitric oxide in the locomotor activity of hypertensive rats. Behav Brain Res 2006 [Epub ahead of print].
12. Pechánová O., Matušková J., Capiková D., Jendeková L., Paulis L., Šimko F. Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats. Kidney Int 70: 170-176, 2006.
13. Reyes A. J. Diuretics in the treatment of patients who present congestive heart failure and hypertension. J Hum Hypertens 16 Suppl 1: S104-113, 2002.
14. Silvestre J. S., Kamsu-Kom N., Clergue M., Duriez M., Levy B. I. Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs. J Pharmacol and Exp Therapeut 303: 1038-1043, 2002.
15. Szilvassy Z., Csont T., Pali T., Droy-Lefaix M. T., Ferdinandy P. Nitric oxide, peroxynitrite and cGMP in atherosclerosis-induced hypertension in rabbits: beneficial effects of cicletanine. J Vasc Res 38: 39-46, 2001.